Molecular Breast Imaging Market
Request Sample Report
Molecular Breast Imaging Market Size and Growth
The Molecular Breast Imaging market is projected to reach $XX million by 2027, driven by rising breast cancer prevalence and technological advancements. Increasing adoption of non-invasive imaging techniques and growing awareness of early detection are influencing market growth, while regulatory challenges and high costs may hinder overall expansion.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Dilon Technologies
◍ CMR Naviscan
◍ Digirad
◍ GE
◍ Mayo Clinic
The Molecular Breast Imaging (MBI) market includes key players like Dilon Technologies, CMR Naviscan, Digirad, GE, and Mayo Clinic. These companies enhance MBI through innovative imaging technologies, clinical applications, and research, contributing to market growth. Sales revenues for select companies are not publicly disclosed but indicate a growing industry trend.
Request Sample Report
Market Segmentation
By Application
Hospital
Diagnostic Center
Others
Request Sample Report
By Product
Single Head Molecular Breast Imaging
Dual Head Molecular Breast Imaging
Market Growth
Request Sample Report
$ 0.43 Billion
